APP and experimental autoimmune encephalomyelitis: More intriguingly, injection of Aβ peptide into experimental autoimmune encephalomyelitis (EAE) delays disease onset; conversely, EAE gets worse following genetic deletion of the amyloid precursor protein (APP) (23).